Opioid addiction is a public health crisis that affects people differently by age, sex, and race. This page explores overdose patterns, including who is most affected and how fentanyl contamination raises risk. You’ll also see why treatment access remains limited, what medication for opioid use disorder can change, and how costs extend beyond healthcare into lost productivity and criminal justice. The goal is clear, practical understanding—from risk to recovery.
Key Takeaways
- In 2021, 16.5% of people with OUD received medications for OUD (MOUD)
- Non-Hispanic White individuals had the highest opioid overdose death rate at 21.0 per 100,000 in 2021
- Males accounted for 69% of opioid overdose deaths in 2022 (56,500+ deaths)
- U.S. opioid crisis costs $1.02 trillion annually in 2017, including $504B healthcare
- Lost productivity from opioid misuse: $504 billion per year
- Opioid overdose deaths cost $1,021 billion in 2020, up from $504B in 2017
- Opioids cause 75% of overdose deaths, leading to 100,000+ annual U.S. fatalities
- Fentanyl contamination causes respiratory depression in 90% of illicit opioid overdoses
- Chronic opioid use leads to tolerance, increasing overdose risk by 5x within first month of abstinence
- In 2021, approximately 5.6 million people aged 12 or older (2.0% of the U.S. population in that age group) had an opioid use disorder (OUD) in the past year
- From 1999 to 2020, nearly 841,000 people died from drug overdoses in the U.S., with opioids involved in 500,000+ of those deaths
- In 2021, 10.5 million people aged 12 or older misused opioids in the past year, including 9.2 million misusing prescription pain relievers and 2.7 million with pain reliever use disorder
- In 2021, only 22% of people with OUD received specialty treatment
- Medications for OUD (buprenorphine, methadone, naltrexone) reduce overdose risk by 50%
- MAT retention rates: 55% at 6 months for buprenorphine vs 20% without meds
Only 16.5% of people with OUD received MOUD in 2021, yet it can cut overdose risk by half.
Related reading
01 · Category
Demographics29 stats
01
In 2021, 16.5% of people with OUD received medications for OUD (MOUD)
02
Non-Hispanic White individuals had the highest opioid overdose death rate at 21.0 per 100,000 in 2021
03
Males accounted for 69% of opioid overdose deaths in 2022 (56,500+ deaths)
04
Adults aged 25-44 had the highest opioid-involved overdose death rate of 42.7 per 100,000 in 2021
05
American Indian/Alaska Native people had opioid overdose rates 35% higher than White people in 2021
06
In 2021, past-year opioid misuse was highest among those aged 18-25 at 5.0%
07
Rural residents had 50% higher opioid prescription rates than urban in early 2010s
08
Among pregnant women, opioid misuse prevalence was 2.8% in 2020
09
Black Americans saw a 38% increase in opioid overdose deaths from 2019-2021
10
Women aged 25-44 experienced a 50% rise in synthetic opioid deaths from 2019-2022
11
Low-income individuals (<$20,000/year) had 2x higher OUD rates (4.5%) than high-income
12
Veterans have 1.5x higher opioid misuse rates (4.8%) than civilians, per VA data 2021
13
Among those with mental illness, opioid misuse is 3x higher (9.2%) vs general population
14
Hispanic/Latino opioid overdose deaths rose 94% from 2019-2022
15
Adults with disabilities have 2.5x higher prescription opioid misuse (7.1%)
16
In Appalachia, 40% of adults report family history of addiction, correlating with higher use
17
Unemployment correlates with 2x OUD risk; 6% rate among unemployed vs 2%
18
College non-graduates have 1.8x higher opioid misuse (4.2%) than graduates
19
Among LGBTQ+ youth, opioid misuse is 2x national average (3.5%)
20
Incarcerated individuals have 10x higher OUD prevalence (50% lifetime)
21
Chronic pain patients from lower education backgrounds misuse at 5.2% rate
22
Native Hawaiian/Pacific Islanders saw 30% rise in opioid deaths 2018-2021
23
Single/divorced adults have 2.3x higher OUD (4.8%) than married
24
In foster care youth, opioid misuse reaches 8% past year
25
Homeless individuals have 40% OUD prevalence
26
Among smokers, opioid misuse is 4x higher (8.1%)
27
Asian Americans have lowest opioid misuse (1.2%), but rising 20% yearly
28
Retired adults over 65 misuse opioids at 2.1%, often due to pain management
29
In tribal lands, opioid death rates are 2x national average (45 per 100k)
Interpretation
Demographics Interpretation
From a demographics perspective, opioid harm is not evenly distributed, with the highest overdose death rate among adults ages 25 to 44 at 42.7 per 100,000 in 2021 and males accounting for 69% of opioid overdose deaths in 2022, alongside disparities such as American Indian and Alaska Native people having rates 35% higher than White people.
02 · Category
Economic Costs28 stats
01
U.S. opioid crisis costs $1.02 trillion annually in 2017, including $504B healthcare
02
Lost productivity from opioid misuse: $504 billion per year
03
Opioid overdose deaths cost $1,021 billion in 2020, up from $504B in 2017
04
Criminal justice costs from opioids: $35.6 billion annually
05
Workplace absenteeism due to OUD: 2.6 extra sick days per year per affected worker
06
Child welfare costs from parental OUD: $5.4 billion yearly
07
Medicare spent $2.4 billion on opioid use disorder services in 2017
08
Emergency department visits for opioids cost $10.5 billion in 2019
09
Treatment costs for OUD: average $15,000per patient per year for residential care
10
Opioid prescriptions lead to $78 billion in excess healthcare spending annually
11
Family members lose $23,000per year in caregiving for OUD patients
12
Unemployment from OUD costs U.S. economy $50 billion in lost wages yearly
13
Neonatal abstinence syndrome hospital costs: $1.6 billion annually for 30,000 cases
14
Incarceration costs for drug offenses: $80 billion/year, 50% opioid-related
15
Insurance claims for opioid overdoses: $2.6 billion in 2018
16
Reduced life expectancy from opioids: 2.5 years lost per overdose death, costing $100k lifetime earnings
17
Foster care placements due to OUD: 40% increase, costing $2 billion extra yearly
18
Workers' comp claims for OUD: doubled to $1 billion from 2010-2018
19
Hospitalizations for opioid poisoning: 400,000/year, $11 billion cost
20
Suicide attempts from OUD cost $1.2 billion in medical care annually
21
Disability claims from chronic pain/opioids: $40 billion/year
22
Law enforcement spending on opioid response: $4.5 billion annually
23
Lost tax revenue from OUD workforce dropout: $25 billion yearly
24
MAT treatment saves $20,000per patient annually vs no treatment costs
25
Opioid litigation settlements from pharma: $50 billion allocated for abatement
26
SAMHSA grants for opioid response: $1.5 billion in FY2022
27
Property crime linked to OUD funding: 20% increase, $10 billion cost
28
Emergency services for overdoses: 1.5 million calls/year, $3 billion cost
Interpretation
Economic Costs Interpretation
The economic costs of the U.S. opioid crisis are enormous and rising, reaching $1.02 trillion each year in 2017, then surging for overdose deaths from $504 billion to $1.021 trillion by 2020, illustrating how opioid addiction steadily drives large healthcare, productivity, and justice burdens under this economic costs category.
03 · Category
Health Impacts30 stats
01
Opioids cause 75% of overdose deaths, leading to 100,000+ annual U.S. fatalities
02
Fentanyl contamination causes respiratory depression in 90% of illicit opioid overdoses
03
Chronic opioid use leads to tolerance, increasing overdose risk by 5x within first month of abstinence
04
Neonatal abstinence syndrome (NAS) affects 7 per 1,000 U.S. births due to maternal opioid use
05
Opioid addiction alters brain dopamine pathways, reducing natural reward response by 40-60%
06
Infectious diseases from injection: 35% of new HIV cases and 10% hepatitis C linked to opioids
07
Overdose survivors have 10x higher risk of subsequent fatal overdose within 1 year
08
Long-term use causes hypogonadism in 50-75% of men, leading to testosterone drop >30%
09
Opioid-induced constipation affects 40-80% of chronic users
10
25% of opioid users develop OUD within 1 year of non-medical use
11
Heart infections (endocarditis) rose 5x from 2011-2018 due to injection opioid use
12
Cognitive impairment persists in 30% of recovering opioid users after 1 year abstinence
13
Opioids increase fracture risk by 2x due to falls and bone density loss
14
Maternal opioid use disorder leads to 2x preterm birth rate (20%)
15
Skin infections and abscesses occur in 65% of injection drug users annually
16
Hyperalgesia develops in 10-30% of long-term opioid users, worsening pain sensitivity
17
Opioid use linked to 1.5x higher suicide risk, with 20% of OUD deaths by suicide
18
Respiratory failure from opioids causes 50% of non-fatal overdoses requiring ventilation
19
Liver damage from acetaminophen in opioid combos affects 15% chronic users
20
Sleep-disordered breathing increases 3x in opioid users, raising cardiac risks
21
70% of OUD patients have co-occurring anxiety/depression, worsening outcomes
22
Neonatal opioid withdrawal lasts 4-6 months, with 55% needing pharmacotherapy
23
Injection-related botulism cases rose 10x since 2015 due to black tar heroin
24
Opioids suppress immune function, increasing pneumonia risk by 2.5x
25
40% of chronic users experience sexual dysfunction
26
Overdose deaths with stimulants + opioids doubled from 2015-2021 to 24,000
27
OUD linked to 3x higher stroke risk in young adults
28
25% of opioid overdose survivors develop PTSD
29
Chronic use causes osteoporosis, with 20% bone density loss over 5 years
30
Wound botulism incidence 1 per 100 injection users yearly
Interpretation
Health Impacts Interpretation
Under the health impacts category, opioids drive most overdose deaths with 75% of fatalities and 100,000+ annual deaths in the US while fentanyl contributes to respiratory depression in 90% of illicit opioid overdoses.
More related reading
04 · Category
Prevalence30 stats
01
In 2021, approximately 5.6 million people aged 12 or older (2.0% of the U.S. population in that age group) had an opioid use disorder (OUD) in the past year
02
From 1999 to 2020, nearly 841,000 people died from drug overdoses in the U.S., with opioids involved in 500,000+ of those deaths
03
In 2021, 10.5 million people aged 12 or older misused opioids in the past year, including 9.2 million misusing prescription pain relievers and 2.7 million with pain reliever use disorder
04
The age-adjusted rate of drug overdose deaths involving synthetic opioids other than methadone (primarily fentanyl) increased 23-fold from 2013 (1.0 per 100,000) to 2022 (23.8 per 100,000)
05
In 2022, opioid-involved overdose deaths reached 81,806, accounting for 75% of all drug overdose deaths in the U.S.
06
Among adults aged 18-25, past-year opioid misuse was reported by 3.2% (about 1.1 million people) in 2021
07
From 2010 to 2021, the rate of opioid dispensing prescriptions decreased by 60%, from 78.5 to 31.2 per 100 persons
08
In 2020, 9.3 million Americans aged 12+ misused prescription opioids in the past year, representing 3.3% of the population
09
Heroin use in the past year among people aged 12+ was 828,000 (0.3%) in 2021
10
Past-year misuse of opioids increased among adults aged 35-50 from 2015-2019, with rates rising to 1.5% by 2019
11
Globally, 60 million people suffer from opioid use disorders, per 2023 UNODC World Drug Report
12
In the EU, opioid-related deaths increased by 39% from 2012 to 2022, reaching 8,000 annually
13
U.S. opioid prescriptions peaked at 255 million in 2012, dropping to 143 million by 2020
14
In 2021, 2.7 million people aged 12+ had a pain reliever use disorder
15
Opioid overdose death rates were highest among males at 41.7 per 100,000 in 2021
16
Past-month opioid misuse among youth aged 12-17 was 0.8% (194,000 people) in 2021
17
Synthetic opioid deaths rose from 3,105 in 2013 to 71,238 in 2021
18
In Appalachia, opioid misuse rates are 50% higher than national average, affecting 4.5% of adults
19
From 2015-2020, opioid use disorder prevalence increased 34% among pregnant women
20
In 2022, fentanyl was involved in 68% of all opioid overdose deaths (55,000+)
21
Past-year heroin use disorder affected 828,000 people aged 12+ in 2021
22
Opioid dispensing rates fell 44% from 2012 to 2022, from 81.3 to 45.7 per 100 persons
23
In Canada, opioid-related hospitalizations increased 43% from 2016-2021 to 24,000 annually
24
U.S. adults with chronic pain using opioids: 8 million (3%), per 2021 data
25
Past-year prescription opioid misuse among females aged 12+ was 3.1% in 2021
26
Opioid use disorder remission rates are low, with only 40% in remission after 10 years
27
In 2020, 2.7% of U.S. adults reported opioid misuse, up from 2.0% in 2015
28
Rural areas saw opioid prescription rates 40% higher than urban in 2012, narrowing by 2020
29
Global opioid consumption for medical use is 90% in high-income countries, per WHO
30
In Australia, opioid prescriptions declined 25% from 2016-2021, but harms rose 15%
Interpretation
Prevalence Interpretation
For the prevalence angle, the data show that opioid misuse and opioid use disorders remain widespread in the United States, with 5.6 million people aged 12 or older having an opioid use disorder and 10.5 million people misusing opioids in 2021, while overdose deaths largely reflect this burden with opioid-involved deaths reaching 81,806 in 2022.
report visual · Projection
Synthetic opioid (non-methadone) overdose death rates rose sharply, then peaked recently
From 2013 to 2022, opioid-involved overdose death rates involving synthetic opioids other than methadone increased overall, with the highest rate in 2022 and a large gap versus ear
1 deaths per 100,000 population
Start
+42.22%
CAGR · 9y
23.8 deaths per 100,000 population
Projected
20132022
source-verifiedcdc.gov2022
05 · Category
Treatment24 stats
01
In 2021, only 22% of people with OUD received specialty treatment
02
Medications for OUD (buprenorphine, methadone, naltrexone) reduce overdose risk by 50%
03
MAT retention rates: 55% at 6 months for buprenorphine vs 20% without meds
04
Naloxone distribution prevented 26,000+ overdose deaths from 1996-2014
05
Only 1 in 5 U.S. counties have adequate opioid treatment capacity
06
Telehealth buprenorphine prescriptions increased 150% during COVID-19, improving access
07
Contingency management boosts abstinence rates by 50% in opioid treatment trials
08
12-step programs like NA show 20-30% long-term abstinence vs 10% without
09
Detox alone has 90% relapse rate within 1 month without follow-up treatment
10
Buprenorphine reduces cravings by 70% and withdrawal symptoms by 80%
11
Methadone maintenance lowers HIV risk by 54% among injectors
12
Cognitive behavioral therapy (CBT) reduces opioid misuse by 40% in 12 weeks
13
Naltrexone implant shows 60% abstinence at 6 months vs 20% oral
14
Peer recovery coaching improves retention by 25%
15
Integrated treatment for co-occurring disorders doubles recovery rates to 50%
16
Harm reduction syringe programs cut HIV incidence by 50% in opioid users
17
Long-acting naltrexone monthly injections achieve 43% abstinence at 6 months
18
Residential treatment 90-day programs yield 40% sobriety at 1 year
19
Fentanyl test strips reduce overdose risk by 30% in user surveys
20
Buprenorphine initiation in ER settings retains 66% in treatment at 30 days
21
Vivitrol (extended-release naltrexone) used by 4% of treated OUD patients in 2021
22
Opioid treatment programs (OTPs) serve 1.5 million patients yearly with methadone
23
Mindfulness-based relapse prevention cuts relapse by 31% vs standard care
24
X-waiver removal in 2023 increased buprenorphine prescribers by 50%
Interpretation
Treatment Interpretation
Despite only 22% of people with OUD receiving specialty treatment in 2021, evidence shows treatment works, since medications for OUD can cut overdose risk by 50% and buprenorphine retention reaches 55% at 6 months compared with 20% without medication, highlighting the urgent need to expand treatment capacity and access.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Henrik Dahl. (2026, February 13). Opiate Addiction Statistics. Gitnux. https://gitnux.org/opiate-addiction-statistics
MLA
Henrik Dahl. "Opiate Addiction Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/opiate-addiction-statistics.
Chicago
Henrik Dahl. 2026. "Opiate Addiction Statistics." Gitnux. https://gitnux.org/opiate-addiction-statistics.